Evaluation of three different strengths of trichloroacetic acid in xanthelasma palpebrarum

被引:25
作者
Haque, MU [1 ]
Ramesh, V [1 ]
机构
[1] Govt NCT Delhi, Deendayal Upadhyay Hosp, Dept Dermatol Venereol & Leprosy, New Delhi, India
关键词
TCA; xanthelasma;
D O I
10.1080/09546630500475708
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Xanthelasma is a common cutaneous condition that presents in the periocular region. Essentially benign, treatment is of cosmetic importance. Objective: Evaluation of varying strengths of trichloroacetic acid (TCA) in xanthelasma palpebrarum. Methods: Three strengths of TCA were used on 51 patients randomly after categorizing their xanthelasma into papulo-nodular, flat plaques and macular lesions. The average number of sittings was calculated in each category and patients were reviewed fortnightly. Results: Papulo-nodular lesions required an average of two applications with 100%, 2.67 with 70% and 4.16 with 50% TCA. Flat plaques responded to an average of 1.43, 1.50 and 3.55 sittings with 100%, 70% and 50% TCA, respectively. Macular lesions responded to only one application of all strengths of TCA applied. Eleven patients developed hypopigmentation, five had hyperpigmentation and one developed mild scarring. Conclusion: 100% TCA gives the best results in papulo-nodular lesions, 100% or 70% TCA give similar results in flat plaque xanthelasma and in macular lesions 50% is sufficient. Hypopigmentation is the commonest side effect, followed by hyperpigmentation. Scarring is a minor problem.
引用
收藏
页码:48 / 50
页数:3
相关论文
共 10 条
[1]  
BORRIE P, 1961, ROXBURGHS COMMON SKI, P428
[2]  
MACKIE RM, 1997, CLIN DERMATOL, P267
[3]  
MADDIN S, 1982, CURRENT DERMATOLOGIC, P618
[4]  
Reddy B S N, 1983, Indian J Dermatol Venereol Leprol, V49, P127
[5]  
Resnik S S, 1976, Cutis, V17, P127
[6]   Xanthelasma palpebrarum: A review and current management principles [J].
Rohrich, RJ ;
Janis, JE ;
Pownell, PH .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2002, 110 (05) :1310-1313
[7]  
SOSIS A, 1982, SKIN DIS DIAGNOSIS M, P196
[8]  
SULZBERGER MB, 1961, DERMATOLOGY DIAGNOSI, P411
[9]  
TUCKER SM, 1996, EYE SKIN DIS, P99
[10]  
WILKINSON DS, 1972, TXB DERMATOLOGY, V2, P2097